Isoniazid + Pyrazinamide + Rifampin
Composition
This formulation contain combination of Isoniazid, Pyrazinamide and Rifampin as active agents
Indications
the treatment of tuberculosis (TB), both active and latent forms.
Side effects
gastrointestinal disturbances, liver toxicity, rash, and hypersensitivity reactions.
Precautions
Patients should be monitored for liver function and should avoid alcohol consumption while taking this Formulation
Contraindications
Contraindications include severe liver disease
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai